From the various areas of modern biotechnologies the so called industrial or white biotechnology has already biggest impact in economy, based on internationally outstanding expertise in science and industry and small and medium sized companies clustered in Northern Europe.
This is an outcome of a workshop held in Tallinn, Sep 23th at the 9th ScanBalt Forum, organised by BioCon Valley. Upcoming products and services will have a strong impact in reducing CO2 burden by an optimal use of biomass for food, feed, fine chemicals.
Industrial biotechnology or white biotechnology is the application of biotechnology for industrial purposes, including manufacturing, alternative energy (or "bioenergy"), and biomaterials. A number of successful products are on the market since years, like enzymes in washing powder, amino acids and vitamins for food and feed industry, and fine chemicals. Global markets are about 58 Billion € per year and estimated to grow 10-30% per year.
In Northern Europe based on strong and international leading research in academic centers in Copenhagen, Vilnius, Greifswald and Hamburg, globally leading industry has grown up, like Novozymes and Danisco in Denmark, Fermentas from Lithuania and Stern Enzymes and Enzymicals in Northern Germany. Examples from these companies and research centers presented their results and innovations which will come into reality in next future.
Dr Ralf Grote, manager of the leading German Cluster BIOCATALYSIS2021 stated: “Our scientific competence in Northern Germany allowed us to assemble the top experts from Germany to boost the development of innovative products and services. And in addition this produces new jobs and companies like the young Enzymicals AG in Greifswald”. Dr. Lutz Popper, head of R&D from Stern Enzymes in Ahrensburg, confirmed the statement and stated “the clustering of expertise is more than a club – it boosts our innovation circle. We now come up with new enzymes for the food and feed industry.” Prof Lene Lange, Dean of Research, AAU, member of the Scanbalt Academy and former R&D director in Novozymes, opened the broad scope of applications of industrial biotechnologies already on the market.
“Industrial Biotechnology is already a leading market of the biotech sector. And upcoming applications will revolutionise the chemical material industry leading to a better and sustainable use of biomass.” As an example for a successful project neoplas GmbH presented results of the cooperation between this SME and the University Greifswald group of Prof. Uwe Bornscheuer Institut for Biochemistry, department of Enzyme engineering and catalysis. For Ulrich Kettling, Global Director Biotechnology & Biorefinery Süd-Chemie AG, industrial biotechnology is an underestimated technology to meet global challenges like climate change and sustainable development.
“We are now building up a biorefinary to replace petrochemical sources by biomass from the farms as a source to synthesize modern chemicals. And we are convinced of our commercial and environmental benefit”. Industrial Biotechnology – the hidden champion based on globally leading expertise in science and industry in Northern Europe, the ScanBalt BioRegion.Weitere Informationen:
Dr. Heinrich Cuypers | idw
Mathematical confirmation: Rewiring financial networks reduces systemic risk
22.06.2017 | International Institute for Applied Systems Analysis (IIASA)
Frugal Innovations: when less is more
19.04.2017 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
20.11.2017 | Earth Sciences
20.11.2017 | Earth Sciences
20.11.2017 | Life Sciences